DENVER – Despite very encouraging progress in the development and use of immunotherapy for patients with non-small cell lung cancer, much confusion remains regarding patient selection for each therapy.

Geneva, Switzerland, 02 May 2017 – Men need more frequent lung cancer screening than women, according to research presented today at the European Lung Cancer Conference (ELCC).

DENVER – Elderly patients with early-stage esophageal cancer that received treatment had an increased 5-year overall survival when compared to patients who received observation with no treatment.

Geneva, Switzerland, 26 April 2017 – Lung cancer patients treated with PD-1/PD-L1 checkpoint inhibitors may be at increased risk of adverse events after receiving the seasonal influenza vaccination, according to the first study measuring this effect.

Lugano, Switzerland, 21 April 2017 – The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) have announced that the 2017 Heine H. Hansen (HHH) Award will be given to Rafal Dziadziuszko, a global leader in clinical thoracic oncology. The award will be presented at the European Lung Cancer Conference (ELCC) 2017, held 5 to 8 May in Geneva, Switzerland.

GENEVA – ESMO and IASLC are pleased to invite journalists to a media brief taking place at the beginning of the European Lung Cancer Conference (ELCC) in the Palexpo Centre in Geneva, on Friday 5 May 2017, from 12:00 to 12:45 CEST.